Brenda Clark’s research while affiliated with Société canadienne du sang and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)


ADHD in children and youth: Part 3—Assessment and treatment with comorbid ASD, ID, or prematurity
  • Literature Review

October 2018

·

42 Reads

·

11 Citations

Paediatrics & Child Health

Brenda Clark

·

Stacey A Bélanger

Attention-deficit hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder. Three position statements have been developed by the Canadian Paediatric Society, following systematic literature reviews. Statement objectives are to: • 1) Summarize the current clinical evidence regarding ADHD, • 2) Establish a standard for ADHD care, and • 3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children and youth with this condition. Specific topics reviewed in Part 3, which focuses on associated autism spectrum disorder, intellectual disability, and prematurity, include the challenges of diagnostic assessment, common presentations, the role of genetics, and treatment, including the benefits of physical activity. Recommendations are based on current guidelines, evidence from the literature, and expert consensus.


Le TDAH chez les enfants et les adolescents, partie 3 : L'évaluation et le traitement en cas d'association au trouble du spectre de l'autisme, au handicap intellectuel ou à la prématurité

October 2018

·

35 Reads

Paediatrics & Child Health

Le trouble de déficit de l’attention/hyperactivité (TDAH) est un trouble neurodéveloppemental chronique. La Société canadienne de pédiatrie a préparé trois documents de principes après avoir effectué des analyses bibliographiques systématiques. Leurs objectifs s’établissent comme suit : • 1) Résumer les données probantes cliniques à jour sur le TDAH. • 2) Établir une norme pour les soins du TDAH. • 3) Aider les cliniciens canadiens à prendre des décisions éclairées et fondées sur des données probantes pour rehausser la qualité des soins aux enfants et aux adolescents qui présentent cette affection. Les sujets abordés dans la partie 3, qui porte sur l’association avec le trouble du spectre de l’autisme (TSA), le handicap intellectuel (HI) et la prématurité, incluent les difficultés liées à l’évaluation dia- gnostique, les présentations courantes, le rôle de la génétique et le traitement, y compris les avantages de l’activité physique. Les recommandations reposent sur les lignes directrices à jour, les données probantes tirées des publications scientifiques et le consensus d’experts.

Citations (1)


... Obtaining a diagnosis of Autism and/or ADHD can be a long and expensive process for individuals, their families, and the healthcare system. Diagnosis may require multiple clinician visits and in-depth cognitive and behavioral assessments before a formal diagnosis is attained (Clark & Bélanger, 2018). Many methods are used to assess attention and EF by clinicians and researchers, including direct (in clinic assessments directed at specific cognitive components) and indirect (questionnaire evaluations of specific cognitive skills or behaviors) assessments (Gómez-Pérez et al., 2016;Toplak et al., 2013). ...

Reference:

Assessing the Contribution of Measures of Attention and Executive Function to Diagnosis of ADHD or Autism
ADHD in children and youth: Part 3—Assessment and treatment with comorbid ASD, ID, or prematurity
  • Citing Article
  • October 2018

Paediatrics & Child Health